EBioMedicine (Feb 2025)
Evaluation of intestinal biopsy tissue preservation methods to facilitate large-scale mucosal microbiota researchResearch in context
- Nicola J. Wyatt,
- Hannah Watson,
- Gregory R. Young,
- Mary Doona,
- Ned Tilling,
- Dean Allerton,
- Andrea C. Masi,
- Tariq Ahmad,
- Jennifer A. Doyle,
- Katherine Frith,
- Ailsa Hart,
- Victoria Hildreth,
- Peter M. Irving,
- Claire Jones,
- Nicholas A. Kennedy,
- Sarah Lawrence,
- Charlie W. Lees,
- Robert Lees,
- Trevor Liddle,
- James O. Lindsay,
- Julian R. Marchesi,
- Miles Parkes,
- Nick Powell,
- Natalie J. Prescott,
- Tim Raine,
- Jack Satsangi,
- Kevin Whelan,
- Ruth Wood,
- Andrew King,
- Luke Jostins-Dean,
- R. Alexander Speight,
- Naomi McGregor,
- Christopher J. Stewart,
- Christopher A. Lamb
Affiliations
- Nicola J. Wyatt
- Translational & Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom; Department of Gastroenterology, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom
- Hannah Watson
- Translational & Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom
- Gregory R. Young
- Translational & Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom
- Mary Doona
- Department of Gastroenterology, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom
- Ned Tilling
- Translational & Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom
- Dean Allerton
- Newcastle Clinical Trials Unit (NCTU), Newcastle University, Newcastle upon Tyne, United Kingdom
- Andrea C. Masi
- Translational & Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom
- Tariq Ahmad
- Department of Gastroenterology, Royal Devon University Healthcare NHS Foundation Trust, Exeter, United Kingdom; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, United Kingdom
- Jennifer A. Doyle
- Translational & Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom
- Katherine Frith
- Newcastle Clinical Trials Unit (NCTU), Newcastle University, Newcastle upon Tyne, United Kingdom
- Ailsa Hart
- Department of Gastroenterology, St Marks Hospital and Academic Institute, Gastroenterology, London, United Kingdom; Department of Surgery and Cancer, Imperial College, London, United Kingdom
- Victoria Hildreth
- Newcastle Clinical Trials Unit (NCTU), Newcastle University, Newcastle upon Tyne, United Kingdom
- Peter M. Irving
- Department of Gastroenterology, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom; School of Immunology & Microbial Sciences, King's College London, London, United Kingdom
- Claire Jones
- Department of Histopathology, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom
- Nicholas A. Kennedy
- Department of Gastroenterology, Royal Devon University Healthcare NHS Foundation Trust, Exeter, United Kingdom; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, United Kingdom
- Sarah Lawrence
- Newcastle Clinical Trials Unit (NCTU), Newcastle University, Newcastle upon Tyne, United Kingdom
- Charlie W. Lees
- Institute of Genetics & Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom; Edinburgh IBD Unit, Western General Hospital, NHS Lothian, Edinburgh, United Kingdom
- Robert Lees
- Department of Gastroenterology, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom
- Trevor Liddle
- Research Informatics Team, Clinical Research, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom
- James O. Lindsay
- Department of Gastroenterology, Barts Health NHS Trust, The Royal London Hospital, London, United Kingdom; Centre for Immunobiology, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom
- Julian R. Marchesi
- Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, St Mary's Hospital, Imperial College London, London, United Kingdom
- Miles Parkes
- Department of Gastroenterology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
- Nick Powell
- Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, St Mary's Hospital, Imperial College London, London, United Kingdom; Department of Gastroenterology, Imperial College Healthcare NHS Trust, London, United Kingdom
- Natalie J. Prescott
- Department of Medical and Molecular Genetics, King's College London, Guy's Hospital, London, United Kingdom
- Tim Raine
- Department of Gastroenterology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
- Jack Satsangi
- Nuffield Department of Medicine, University of Oxford, Old Road Campus, Oxford, United Kingdom
- Kevin Whelan
- Department of Nutritional Sciences, King's College London, London, United Kingdom
- Ruth Wood
- Newcastle Clinical Trials Unit (NCTU), Newcastle University, Newcastle upon Tyne, United Kingdom
- Andrew King
- Department of Gastroenterology, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom
- Luke Jostins-Dean
- Kennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom
- R. Alexander Speight
- Translational & Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom; Department of Gastroenterology, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom
- Naomi McGregor
- Newcastle Clinical Trials Unit (NCTU), Newcastle University, Newcastle upon Tyne, United Kingdom
- Christopher J. Stewart
- Translational & Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom
- Christopher A. Lamb
- Translational & Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom; Department of Gastroenterology, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom; Corresponding author. M3.054, William Leech Building, Translational & Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, NE2 4HH, United Kingdom.
- Journal volume & issue
-
Vol. 112
p. 105550
Abstract
Summary: Background: Large-scale multicentre studies are needed to understand complex relationships between the gut microbiota, health and disease. Interrogating the mucosal microbiota may identify important biology not captured by stool analysis. Gold standard tissue cryopreservation (‘flash freezing’) limits large-scale study feasibility. We aimed to compare gut microbiota in gold standard and pragmatic mucosal biopsy storage conditions. Methods: We collected endoscopic recto-sigmoid biopsies from 20 adults with inflammatory bowel disease. Biopsies were preserved using three methods: (i) flash freezing (most proximal and distal biopsy sites); (ii) nucleic acid preservative reagents (QIAGEN Allprotect®, Invitrogen RNAlater™, and Zymo DNA/RNA Shield™); and (iii) formalin fixation with paraffin embedding (FFPE), which is used to preserve tissue for clinical histopathology within healthcare settings. Microbiota were sequenced on the MiSeq platform (V4 region, 16S rRNA gene). Findings: Tissue microbiota were consistent between most proximal and distal tissue suggesting any within-patient variation observed reflected storage condition, not biopsy location. There was no significant difference in alpha-diversity or microbial community profiles of reagent-preserved versus gold standard tissue. FFPE community structure was significantly dissimilar to other tissue samples, driven by differential relative abundance of obligate gut anaerobes; Faecalibacterium, Anaerostipes and Lachnospiraceae. Despite these differences, tissue microbiota grouped by participant regardless of preservation and storage conditions. Interpretation: Preservative reagents offer a convenient alternative to flash freezing tissue in prospective large-scale mucosal microbiota studies. Whilst less comparable, FFPE provides potential for retrospective microbiota studies using historical samples. Funding: Medical Research Council (MR/T032162/1) and The Leona M. and Harry B. Helmsley Charitable Trust (G-2002-04255).